Loading clinical trials...
Loading clinical trials...
This is a registry study in adult patients with newly diagnosed or refractory/relapsed acute myeloid leukemia. Investigator's sites: 51 sites in Germany. Primary objectives: * Identification of epi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Technische Universität Dresden
NCT05907057 · Acute Myeloid Leukemia (AML)
NCT07500441 · Acute Myeloid Leukemia (AML)
NCT05768932 · Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer, and more
NCT05756777 · Acute Myeloid Leukemia (AML)
NCT04990102 · Acute Myeloid Leukemia (AML) in Remission
Klinikum Mittelbaden
Baden-Baden, Baden-Wurttemberg
Universtitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg
Klinikum Mannheim GmbH
Mannheim, Baden-Wurttemberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions